共 47 条
- [1] HER1-ECD vaccination dispenses with emulsification to elicit HER1-specific anti-proliferative effects [J]. HUMAN VACCINES, 2009, 5 (03): : 158 - 165
- [2] Amin DN., 2010, SEMINARS CELL DEV BI
- [3] Bergado-Baez G., 2022, Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies, V12, DOI [10.3389/fonc.2022.951267, DOI 10.3389/FONC.2022.951267]
- [5] Caballero I., 2017, Safety and immunogenicity of a human epidermal growth factor receptor 1 (HER1)-based vaccine in prostate castration-resistant carcinoma patients: a dose-escalation phase I study trial, V8, P263, DOI [10.3389/fphar.2017.00263, DOI 10.3389/FPHAR.2017.00263]
- [6] Campbell MR., 2010, HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy, V16, P1373, DOI [10.1158/1078-0432.CCR-09-1218, DOI 10.1158/1078-0432.CCR-09-1218]
- [7] Chen L., 2011, Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3, V17, P6218, DOI [10.1158/1078-0432.CCR-11-1548, DOI 10.1158/1078-0432.CCR-11-1548]
- [8] Cleary KL., 2017, Antibody distance from the cell membrane regulates antibody effector mechanisms, V198, P3999, DOI [10.4049/jimmunol.1601473, DOI 10.4049/JIMMUNOL.1601473]
- [9] Engelman JA., 2007, MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling, V316, P1039, DOI DOI 10.1126/SCIENCE.1141478
- [10] Cancer vaccines: Between the idea and the reality [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) : 630 - 641